uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)

uniQure's (QURE) quarterly Non-Current Deffered Revenue came in at $22.4 million in Q3 2020, down 6.15% year-on-year from $23.9 million in Q4 2019, and down 2.76% quarter-over-quarter from $23.0 million in Q2 2020.

uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends

uniQure's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $22.4 million for Q3 2020.

  • On a quarterly basis, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million in Q3 2020; TTM through Sep 2020 was $22.4 million, a 6.15% decrease from a year earlier, with the FY2019 full-year figure at $23.1 million, up 164.1% from the prior year.
  • Non-Current Deffered Revenue slipped to $22.4 million in Q3 2020 per QURE's latest filing, from $23.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $67.9 million in Q3 2017 and bottomed at $6.8 million in Q4 2016.
  • The 5-year median for Non-Current Deffered Revenue is $23.8 million (2019), against an average of $27.3 million.
  • Across the five-year window, Non-Current Deffered Revenue surged 894.07% in 2017 and sank 87.0% in 2018, its largest moves.
  • Year by year, Non-Current Deffered Revenue stood at $6.8 million in 2016, then jumped by 894.07% to $67.4 million in 2017, then sank by 87.0% to $8.8 million in 2018, then soared by 164.1% to $23.1 million in 2019, then slipped by 3.13% to $22.4 million in 2020.
  • Per Business Quant, the three latest QURE Non-Current Deffered Revenue figures stand at $22.4 million (Q3 2020), $23.0 million (Q2 2020), and $23.7 million (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 22.41 Mn
Jun 30, 2020 23.05 Mn
Mar 31, 2020 23.71 Mn
Dec 31, 2019 23.14 Mn
Sep 30, 2019 23.88 Mn
Jun 30, 2019 26.35 Mn
Mar 31, 2019 27.47 Mn
Dec 31, 2018 8.76 Mn
Sep 30, 2018 29.85 Mn
Jun 30, 2018 32.85 Mn
Mar 31, 2018 36.15 Mn
Dec 31, 2017 67.41 Mn
Sep 30, 2017 67.86 Mn
Jun 30, 2017 8.49 Mn
Mar 31, 2017 8.09 Mn
Dec 31, 2016 6.78 Mn
Dec 31, 2015 6.25 Mn